← FDA Drug Approvals (Drugs@FDA)
KRINTAFEL
NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 2018-07-20
Drug application
- FDA Application #
NDA210795- Application type
- New Drug Application
- Brand name
- KRINTAFEL
- Generic name
- TAFENOQUINE SUCCINATE
- Active ingredients
- TAFENOQUINE SUCCINATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- GLAXOSMITHKLINE
- Manufacturer
- GlaxoSmithKline LLC
- First approval
- 2018-07-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown